- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03720743
Effect of Biodanza on Desire, Excitation and Sexual Inhibition
Effect of a Biodanza Program on Desire, Excitation and Sexual Inhibition in Young Adults. A Randomized Pilot Study
the objective of this study was to examine the effects of a 10 weeks biodanza program on the sexual desire and inhibition/arousal of a sample of healthy young adults.
A randomized clinical study was carried out, involving a total of 86 young adults divided into Intervention Group (BG) and Control Group (CG), carrying out biodanza sessions during 10 weeks. The Sexual Desire Inventory (SDI) and the Sexual Inhibition/Sexual Arousal-Short Form Scale (SIS/SES-SF) were completed before and after the intervention.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Almería, Spain, 04120
- Universidad de Almeria
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- at least 18 years old
- having correctly completed the online questionnaire.
- to attend a minimum of eight Biodanza sessions.
Exclusion Criteria:
- exceed 30 years old.
- the presence of some type of physical or mental disability that could prevent their participation in the therapy or the completion of the questionnaires.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Biodanza
Intervention group received a total of 10 sessions, once a week, over the course of two months.
Each session lasted 60 minutes.
All sessions began with a 10-minute warm-up period combining music and low-intensity movements as a welcome round, followed individual exercises, in pairs and/or groups, which included dance combined with exercises based on the five lines of Biodanza (vitality, sexuality, creativity, affectivity and transcendence).
Finally, a celebration and farewell round of 10 minutes was held.
At the end of each session, the participants were asked to share their experiences with the rest of the group.
|
Intervention group received a total of 10 sessions, once a week, over the course of two months.
Each session lasted 60 minutes.
All sessions began with a 10-minute warm-up period combining music and low-intensity movements as a welcome round, followed individual exercises, in pairs and/or groups, which included dance combined with exercises based on the five lines of Biodanza (vitality, sexuality, creativity, affectivity and transcendence).
Finally, a celebration and farewell round of 10 minutes was held.
At the end of each session, the participants were asked to share their experiences with the rest of the group.
Other Names:
|
|
No Intervention: Control Group
The study allowed control group subjects to participate in Biodanza sessions after the follow-up period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sexual desire
Time Frame: 3 months
|
Sexual Desire Inventory (SDI) formed by 13 items, divided into dyadic sexual desire (Dyadic SD) (items 1-9) and solitary sexual desire (Solitary SD) (items 10-13), and valued by a Likert scale according to frequency (0 = never, and 7 = more than once a day), and intensity (0 = not desire, and 8 = strong desire), in a total range between 0 and 101 points, being higher the desire the greater the response result.
|
3 months
|
|
Sexual excitement/sexual inhibition
Time Frame: 3 months
|
Sexual Inhibition/Sexual Excitement Scales - Short Form consists of 14 items with responses assessed using a Likert scale 1-4 (1 = completely agree; 4 = completely disagree) that measure three sub-scales: Sexual Excitation Scale (SES) (items 1, 3, 8, 10, 11, 14) with a score range between 4 and 16; Sexual Inhibition Scale 1 (SIS1) (items 4, 9, 12, 13) related to distraction/concentration in sexual performance, with a range between 4 and 16, and Sexual Inhibition Scale 2 (SIS2) (items 2, 5, 6, 7) related to the fear to be discovered or to contract some type of sexually transmitted infection (STI), with a range between 4 and 16.
|
3 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- amuelle
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sexual Arousal Disorder
-
Kern Pharma, S.L.Analysis and Research Network, S.LUnknownFemale Sexual Arousal DisorderSpain
-
University of Texas at AustinCompletedFemale Sexual Arousal DisorderUnited States
-
Dalhousie UniversityUniversity of British Columbia; Université de MontréalRecruitingSexual Interest/Arousal DisorderCanada
-
Biozeus Biopharmaceutical S.A.RecruitingFemale Sexual Dysfunction | Female Sexual Arousal DisorderBrazil
-
Biozeus Biopharmaceutical S.A.Not yet recruitingFemale Sexual Arousal Disorder | Female Sexual Dysfunction (FSD)Brazil
-
Procare Health Iberia S.L.WithdrawnFemale Sexual Interest/Arousal DisorderSpain
-
University of Texas at AustinCompletedFemale Sexual Arousal DisorderUnited States
-
Cedars-Sinai Medical CenterTerminatedFemale Sexual Arousal DisorderUnited States
-
Radboud University Medical CenterCompletedArousal Disorders, SexualNetherlands
-
Strategic Science & Technologies, LLCDaré Bioscience, Inc.RecruitingFemale Sexual Arousal DisorderUnited States
Clinical Trials on Biodanza
-
Universidad de AlmeriaCompletedMood Disorders | Mental Disorder | Physically Disabled | Alzheimer Dementia (AD)Spain
-
Universidad de AlmeriaCompleted